Data / Drug companies / Meclizine hydrochloride
Meclizine hydrochloride: 41 companies and 84 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Meclizine hydrochloride is listed in the FDA National Drug Code Directory by 41 companies, with 84 products in commercial distribution. 31 of the products (36.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, chewable; tablet, film coated, and the newest product started marketing on August 21, 2026.
The request: Get every company that lists meclizine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 41
- Products
- 84
- Generic (ANDA) products
- 31 (36.9%)
- Application numbers
- 8
- Routes
- Oral
- Brand names
- Dramamine, Bonine, Dramamine Less Drowsy, Meclizine HCl, Dramamine Chewable Orange, Wal-Dram 2 Quick-Dissolving, Dramamine - N, Bonine Max
- openFDA record search
- api.fda.gov
Companies that list meclizine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Medtech Products Inc. | 7 | tablet, chewable; tablet | Over the counter monograph drugs | August 1, 2026 |
| Bryant Ranch Prepack | 5 | tablet; tablet, chewable | Authorized generics (NDA) | October 30, 2020 |
| NuCare Pharmaceuticals,Inc. | 5 | tablet; tablet, chewable | Generic drugs (ANDA) | October 30, 2020 |
| A-S Medication Solutions | 4 | tablet, chewable; tablet | Over the counter monograph drugs | October 30, 2020 |
| Rising Pharma Holdings, Inc. | 4 | tablet; tablet, chewable | Authorized generics (NDA) | January 15, 2020 |
| WellSpring Pharmaceutical Corporation | 4 | tablet, chewable | Over the counter monograph drugs | April 1, 2025 |
| Apnar Pharma LP | 3 | tablet | Over the counter monograph drugs | November 21, 2022 |
| Asclemed USA, Inc. | 3 | tablet | Authorized generics (NDA) | January 15, 2020 |
| Chartwell RX, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | August 11, 2022 |
| Proficient Rx LP | 3 | tablet | Authorized generics (NDA) | January 15, 2020 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | September 8, 2023 |
| Amneal Pharmaceuticals LLC | 2 | tablet | Generic drugs (ANDA) | February 12, 2010 |
| Amneal Pharmaceuticals of New York LLC | 2 | tablet | Generic drugs (ANDA) | April 22, 2022 |
| Direct_Rx | 2 | tablet | Authorized generics (NDA) | September 1, 2022 |
| Epic Pharma, LLC | 2 | tablet | Generic drugs (ANDA) | April 30, 2012 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | April 22, 2022 |
| QPharma, Inc. | 2 | tablet | Generic drugs (ANDA) | April 22, 2022 |
| Redpharm Drug | 2 | tablet | Generic drugs (ANDA) | October 29, 2020 |
| Remedyrepack Inc. | 2 | tablet | Authorized generics (NDA) | August 2, 2023 |
| Walgreen Company | 2 | tablet, orally disintegrating; tablet, chewable | Over the counter monograph drugs | March 22, 2023 |
| Zydus Lifesciences Limited | 2 | tablet | Generic drugs (ANDA) | October 29, 2020 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | October 29, 2020 |
| Advanced Rx LLC | 1 | tablet, chewable | Over the counter monograph drugs | December 1, 2024 |
| Advanced Rx of Tennessee, LLC | 1 | tablet | Authorized generics (NDA) | February 2, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, chewable | Over the counter monograph drugs | October 30, 2020 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | August 8, 2013 |
| BluePoint Laboratories | 1 | tablet | Over the counter monograph drugs | March 14, 2022 |
| CVS Pharmacy | 1 | tablet, orally disintegrating | Over the counter monograph drugs | August 27, 2015 |
| CVS Pharmacy | 1 | tablet | Over the counter monograph drugs | August 13, 2020 |
| Coupler LLC | 1 | tablet | Authorized generics (NDA) | August 21, 2026 |
| Navajo Manufacturing Company Inc. | 1 | tablet | Over the counter monograph drugs | February 18, 2026 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | October 7, 2022 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | June 11, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, chewable | Over the counter monograph drugs | October 30, 2020 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Authorized generics (NDA) | April 16, 2024 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | April 30, 2012 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Over the counter monograph drugs | July 22, 2024 |
| Rugby Laboratories | 1 | tablet, chewable | Over the counter monograph drugs | October 30, 2020 |
| Sato Pharmaceutical Co., Ltd. | 1 | tablet | Over the counter monograph drugs | May 1, 2021 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Authorized generics (NDA) | June 21, 2021 |
| Target Corporation | 1 | tablet | Over the counter monograph drugs | November 5, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 60 | 71.4% |
| Tablet, chewable | 18 | 21.4% |
| Tablet, film coated | 3 | 3.6% |
| Tablet, orally disintegrating | 2 | 2.4% |
| Powder | 1 | 1.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 31 | 36.9% |
| Generic drugs (ANDA) | 31 | 36.9% |
| Authorized generics (NDA) | 22 | 26.2% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antiemetic | 84 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.